Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide pens like Ozempic® deliver steady weekly injections for weight management, but their lifespan after opening depends on storage conditions and handling. Once you puncture the pen for your first dose, a 28-day countdown begins, regardless of how many doses remain. Proper storage ensures your medication stays potent and safe throughout that window.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

How Long Does an Ozempic Pen Last Once Opened

The critical rule for opened semaglutide pens is straightforward: use the pen within 28 days of first injection or discard it. This 28-day window applies even if you haven't used all the medication inside the pen. Manufacturers establish this timeframe based on stability testing that accounts for exposure to air, temperature fluctuations, and potential bacterial contamination after the needle pierces the rubber septum.

After 28 days, the pharmaceutical integrity of the semaglutide solution degrades, meaning potency decreases and sterility cannot be guaranteed. Unopened pens, by contrast, remain stable until the printed expiration date on the box—typically 2 to 3 years from manufacture. This distinction matters when planning refills and understanding your treatment schedule.

Proper Temperature Control for Semaglutide Pens

Before opening, store your semaglutide pen in the refrigerator between 36°F and 46°F (2°C and 8°C). Keep the cap on and protect it from direct light. Never freeze unopened pens, as freezing damages the medication and renders it unusable. If your pen accidentally freezes, discard it rather than risk injection of a compromised solution.

Once you've used the pen for the first time, you may keep it at room temperature—up to 86°F (30°C)—for those 28 days. Some patients prefer refrigeration for psychological comfort or to reduce injection-site reactions, and this is safe if the temperature stays within the 36–46°F range. The key is consistency: avoid moving the pen repeatedly between the refrigerator and counter, which creates condensation and temperature stress.

Storage Best Practices to Extend Medication Stability

Store your opened pen in a cool, dark place—ideally a refrigerator shelf away from the back wall where temperatures dip lower. Keep it upright in its original pen holder or a dedicated medication case that blocks light exposure. Never store semaglutide pens in the door of the refrigerator, where temperature swings are largest each time the door opens.

Traveling with your pen requires a special cooling case or insulin travel pouch that maintains 36–46°F for several hours. Avoid leaving your pen in hot cars, direct sunlight, or near heat sources like radiators or ovens. Document the date you first use each pen on the barrel with a marker so you never accidentally use it beyond the 28-day window. This simple step prevents medication waste and protects your health.

Semaglutide Injection Options at PlexusDx

PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A compounding pharmacies available in all 50 states. Unlike brand-name Ozempic®, compounded formulations help reduce out-of-pocket costs while maintaining the same active ingredient and clinical efficacy. Your dose may need to go up as your body responds to treatment, but PlexusDx pricing remains flat regardless of dose strength.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

What happens if I use an Ozempic pen after 28 days of opening?

Using semaglutide beyond 28 days after opening risks reduced potency and possible bacterial growth, which can cause injection-site infections or allergic reactions. Discard any open pen that has exceeded the 28-day window, even if medication remains inside. Your health and treatment effectiveness depend on using fresh, sterile medication.

Can I refrigerate my semaglutide pen after opening if I prefer?

Yes. Once opened, you may store your pen at room temperature (up to 86°F) or in the refrigerator (36–46°F) for the full 28 days. Choose whichever method you're most comfortable with, but avoid moving it back and forth repeatedly, as temperature fluctuations can damage the solution.

How much does compounded semaglutide cost at PlexusDx compared to brand-name Ozempic?

PlexusDx compounded semaglutide injections start at just $189/mo (or $149/mo on the 6-month plan)—significantly lower than the typical $900–$1,300 monthly copay for brand-name Ozempic. Your price stays flat as your dose increases, with no insurance required and HSA/FSA eligibility available in all 50 states.

Does freezing an unopened semaglutide pen permanently ruin it?

Yes. Freezing damages the molecular structure of semaglutide and makes the pen unsafe and ineffective. Never use a frozen pen, and always store unopened pens in your refrigerator (36–46°F), never in the freezer. If accidental freezing occurs, dispose of the pen and contact your pharmacy for a replacement.

How does the PlexusDx Precision Peptide Genetic Test help optimize my semaglutide therapy?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves